AQP9 and hepatocellular carcinoma: The results revealed that cell proliferative activity (Figure 8A) and the expression of PCNA (Figure 8B) were significantly downregulated in HCC cells transfected with LV-AQP9, which was abolished by SKL2001 treatment.